Bridging Study to Eliminate Presence of MRD for Acute Leukemia Before HCT
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
Entospletinib Monotherapy and in Combination With Chemotherapy in Adults With Acute Myeloid Leukemia (AML)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Deferasirox, Cholecalciferol, and Azacitidine in the Treatment of Newly Diagnosed AML Patients Over 65
- Status
- TERMINATED
- Phase
- PHASE2
First-in-Human Study of FLX925 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
Peginterferon Alfa-2a to Enhance Anti-leukemic Responses After Allogeneic Transplantation in Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Safety Study of SGN-CD33A in Combination With Standard-of-care in Patients With AML
- Status
- COMPLETED
- Phase
- PHASE1
Idarubicin Plus Cytarabine (IA) vs IA Plus Cladribine (IAC) as Induction Regimen to Treat Initially Diagnosed Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE3
Azacytidine (Vidaza®) Versus Fludarabine and Cytarabine (Fluga Scheme) in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
Velcade and Lenalidomide in Patients With Relapsed AML and MDS After Allogeneic Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE1
A Study of ASP2215 in Combination With Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia.
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Palbociclib in MLL-rearranged Acute Leukemias
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Study of RO6870810/TEN-010 in Participants With Acute Myeloid Leukemia and Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1
A Study Assessing tOTX015 in Combination With Azacitidine (AZA) or AZA Single Agent in Patients With Newly-diagnosed Acute Myeloid Leukemia (AML) Not Candidate for Standard Intensive Induction Therapy (SIIT)
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Study of Crenolanib in Combination With Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia and Activating FLT3 Mutations
- Status
- TERMINATED
- Phase
- PHASE3
Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCT
- Status
- COMPLETED
- Phase
- PHASE2
Phase 1 Study of SGI-110 in Patients With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
CPX-351 in Treating Patients With Newly Diagnosed, High-Risk Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
1336GCC: Study of Erwinaze for Treatment of Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy of Human Myeloid Progenitor Cells (CLT-008) During Chemotherapy for Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Idarubicin at Different Dosages as Induction Therapy for Newly Diagnosed Acute Myeloid Leukaemia
- Status
- UNKNOWN
- Phase
- PHASE4